Highly awaited Alzheimer’s drug hit by delays
Washington (AFP) - Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US ...
Washington (AFP) - Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US ...
Washington (AFP) - A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated ...
© 2023 - Premium news by MagnifyPost.